HemaSphere

eISSN: 2572-9241pISSN: 2572-9241
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
5.4
Impact Factor
5 - 10
Scite Index
0.90 5-Year SI
SJR
Q3Hematology
SNIP
0.9
4
Time to Publish
time-to-publish View Chart
6  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    LIPPINCOTT WILLIAMS & WILKINS
  • Language
    English
  • Frequency
    Monthly
  • Article Processing Charges
    USD 1200
  • Publication Time
    7
  • Editorial Review Process
    Double anonymous peer review
General Details
  • Language
    English
  • Society/Institute/Sponsor
    European Hematology Association
  • Frequency
    Monthly
  • Publication Start Year
    2017
  • Publisher URL
  • Website URL
Publication Details
Editorial Review Detail
Information for authors
  • Author instructions
  • Deposit Policy
    Sherpa/Romeo
  • License type
    CC BY, CC BY-NC, CC BY-SA, CC BY-NC-ND, CC BY-ND, CC BY-NC-SA
  • OA statement
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 7%
4-6 52%
7-9 27%
>9 14%

Topics Covered

Precision medicine
Bone marrow
Coagulopathy
Immune thrombocytopenia
Chimeric antigen receptor
Minimal residual disease
Dexamethasone
Cancer predisposition
Anemia
Von willebrand
Mantle cell lymphoma
Myelofibrosis
Fusion gene
Therapy-Related Acute Myeloid Leukemia
Ex vivo
Ibrutinib
Hematopoietic stem cell transplantation
Drug resistance
Overall survival
Essential thrombocythemia

Recently Published Papers

Year-wise Publication

FAQs

Since when has HemaSphere been publishing? Faqs

The HemaSphere has been publishing since 2017 till date.

How frequently is the HemaSphere published? Faqs

HemaSphere is published Monthly.

Who is the publisher of HemaSphere? Faqs

The publisher of HemaSphere is LIPPINCOTT WILLIAMS & WILKINS.

How can I view the journal metrics of HemaSphere on editage? Faqs

For the HemaSphere metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of HemaSphere? Faqs

The eISSN number is 2572-9241 and pISSN number is 2572-9241 for HemaSphere.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Precision medicine, Bone marrow, Coagulopathy, Immune thrombocytopenia, Chimeric antigen receptor, Minimal residual disease, Dexamethasone, Cancer predisposition, Anemia, Von willebrand, Mantle cell lymphoma, Myelofibrosis, Fusion gene, Therapy-Related Acute Myeloid Leukemia, Ex vivo, Ibrutinib, Hematopoietic stem cell transplantation, Drug resistance, Overall survival, Essential thrombocythemia.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.